reference/11388687

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11388687

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	312
issn	0007-0920 1532-1827
issueIdentifier	2
pageRange	304-312
publicationName	British Journal of Cancer
startingPage	304
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5d79a8e1f4e45e7eac031cf9559107f1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_79fc4ca7c6fe373f4a169098685ed259 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab1e77cf2378e9a687fd4eeff409713e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8ab8db372b62663afff9f62e17921d28
bibliographicCitation	Khatri A, Williams BW, Fisher J, Brundage RC, Gurvich VJ, Lis LG, Skubitz KM, Dudek AZ, Greeno EW, Kratzke RA, Lamba JK, Kirstein MN. SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours. British Journal of Cancer. 2013 Dec 03;110(2):304–12. doi: 10.1038/bjc.2013.738.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6bf8570fc12792933d3ce585f262cb98 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2dec3dc9467e57b4f94eba57332dbe1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_336df13df05cc75775fe5f850999ca0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_faa09f152f87c4c00a82ac7cfe1dd5d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc3fb35fa5a1322c4eea6190e855bb0f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c385d7e3a86e0bfc2a5bd0f4bafaf21 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a86e216124829cad31a13ac0b161ff41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cbabc563ea69831390823d4461af400 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef16ba845f978c2c948838a47ac92e0f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8fee0456b896b171e5547057edcd8116 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0ef0336850b946eea4e79256948e469 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9fc56fff9f257fa35a9ce5d6773991d
date	2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/24300978 https://doi.org/10.1038/bjc.2013.738 https://pubmed.ncbi.nlm.nih.gov/PMC3899768
isPartOf	https://portal.issn.org/resource/ISSN/1532-1827 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765 https://portal.issn.org/resource/ISSN/0007-0920
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours
discusses	http://id.nlm.nih.gov/mesh/M0179277 http://id.nlm.nih.gov/mesh/M0495201 http://id.nlm.nih.gov/mesh/M0024108 http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M0005569 http://id.nlm.nih.gov/mesh/M0001471 http://id.nlm.nih.gov/mesh/M0379230 http://id.nlm.nih.gov/mesh/M000754277
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_320e990781343ed266cc0ffc49fbbf5a http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cf2508f19af544b3ab4935ddb7414a9d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9871558 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130659 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7057b2e7a94b87d69ed3dce3bf12d055 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64078

Total number of triples: 58.